Cutting-edge technologies can be used to anticipate functional and clinical impact of new variants of SARS-CoV-2

In a recent review in Clinical Proteomics, Dr. Andrei Drabovich and his team from University of Alberta provide insights on the use of cutting-edge technologies to empower basic and clinical research on COVID-19. Most importantly, they describe how these methodologies can be used to detect existing and novel viral variants. Mass spectrometry is a … Continue reading Cutting-edge technologies can be used to anticipate functional and clinical impact of new variants of SARS-CoV-2